VKTX
Viking Therapeutics, Inc.
$28.45
-4.47%
$3.3B
No data for this timeframe.
Vol
Market Cap$3.3B
Cap SizeMid Cap
Analyst ConsensusStrong Buy (88%)
Inst. Holders7 funds
Inst. Value$822.6M
Inst. Activity0 buys / 1 sells
Insider Activity1B / 0S
Insider Net $$149.9K
Reddit Sentiment50° Neutral
SEC Reports1
Recent Activity
Jun 1, 2026
Insider
Chen Hubert C sold 190,000 shares
Chief Medical Officer @ $0.00 ($0.00)
May 12, 2026
short_interest
FTD: VKTX — 25,783 shares ($0.8M) failed to deliver
Settlement: 20260512, Price: $31.72, FTD Value: $817,836.76, VIKING THERAPEUTICS INC COM
Apr 1, 2026
SEC
Viking Therapeutics is holding its 2026 annual shareholder meeting to vote on director elections, auditor selection, and
DEFA14A — Impact 2/10
Mar 10, 2026
Insider
Aubuchon Neil William bought 4,475 shares
Chief Commercial Officer @ $33.50 ($149.9K)
Inst.
BANK OF AMERICA CORP — TRIM
346,647 shares ($12.2M)
Inst.
FMR LLC — TRIM
5,790,051 shares ($152.2M)
Price Targets
$92.58
+225.4% upside
Strong Buy
Current $28.45
Low $34.00
Median $95.00
High $125.00
19 analysts
$34.00
$125.00
Analyst Ratings
9Strong Buy
14Buy
3Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 28, 2026 | Lake Street | INITIATE | Buy |
| May 1, 2026 | BTIG | REITERATE | Buy → Buy |
| Apr 30, 2026 | Cantor Fitzgerald | MAINTAIN | Overweight → Overweight |
| Mar 23, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| Nov 12, 2025 | Canaccord Genuity | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-1.21 ▲ +1.9% | $-1.39 — $-0.83 | -108% YoY | 16 |
| Current FY | $-4.72 | $-5.72 — $-3.81 | -48% YoY | 16 |
| Next Q | $-1.10 ▲ +0.9% | $-1.45 — $-0.75 | -36% YoY | 16 |
| Next FY | $-4.57 ▼ -0.6% | $-6.41 — $-2.22 | 3% YoY | 17 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $351.3M | — |
| FMR LLC | $230.7M | TRIM |
| MORGAN STANLEY | $108.2M | ADD |
| TWO SIGMA INVESTMENTS, LP | $85.7M | ADD |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $24.6M | NEW |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 1, 2026 | Chen Hubert | A | $0.00 |
| Mar 10, 2026 | Aubuchon Neil | BUY | $149.9K |
Reddit Sentiment
50°
Neutral
Bearish
Neutral
Bullish
7 institutional holders with $822.6M total value (23,382,466 shares) as of 2025-Q4. Top holders: VANGUARD, FMR, MORGAN. Net selling activity: 1 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 9,984,487 | $351.3M | 42.7% | — |
| 2 | FMR LLC | 6,557,766 | $230.7M | 28.0% | TRIM -41.0% |
| 3 | MORGAN STANLEY | 3,076,270 | $108.2M | 13.2% | ADD +38.3% |
| 4 | TWO SIGMA INVESTMENTS, LP | 2,435,737 | $85.7M | 10.4% | ADD +58.7% |
| 5 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 700,295 | $24.6M | 3.0% | NEW |
| 6 | BANK OF AMERICA CORP /DE/ | 346,647 | $12.2M | 1.5% | TRIM -40.1% |
| 7 | WELLS FARGO & COMPANY/MN | 281,264 | $9.9M | 1.2% | ADD +76.5% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | TRIM | 578,268 | 346,647 | -40.1% | $12.2M | 2025-Q4 |
| FMR LLC | TRIM | 9,821,897 | 5,790,051 | -41.0% | $152.2M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | ADD | 1,313,783 | 2,085,487 | +58.7% | $54.8M | 2025-Q3 |
| UBS Group AG | ADD | 951,527 | 1,412,308 | +48.4% | $37.1M | 2025-Q3 |
| WELLS FARGO & COMPANY/MN | ADD | 177,068 | 312,520 | +76.5% | $8.2M | 2025-Q3 |
| Duquesne Family Office LLC | EXIT | 549,295 | 0 | -100.0% | $0.00 | 2025-Q3 |
| NORGES BANK | EXIT | 1,767,777 | 0 | -100.0% | $0.00 | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 32,700 | 0 | -100.0% | $0.00 | 2025-Q3 |
| NORGES BANK | NEW | — | 1,767,777 | — | $46.8M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 52,414 | 1,313,783 | +2406.5% | $34.8M | 2025-Q2 |
| UBS Group AG | ADD | 596,660 | 951,527 | +59.5% | $25.2M | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | ADD | 361,710 | 524,772 | +45.1% | $13.9M | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | ADD | 95,472 | 177,068 | +85.5% | $4.7M | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | NEAR_EXIT | 327,700 | 32,700 | -90.0% | $866.5K | 2025-Q2 |
| Duquesne Family Office LLC | NEW | — | 549,295 | — | $14.6K | 2025-Q2 |
| FMR LLC | TRIM | 16,715,438 | 11,249,337 | -32.7% | $271.7M | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 327,700 | — | $7.9M | 2025-Q1 |
| WELLS FARGO & COMPANY/MN | TRIM | 261,635 | 95,472 | -63.5% | $2.3M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 52,414 | — | $1.3M | 2025-Q1 |
| NORGES BANK | EXIT | 1,278,928 | 0 | -100.0% | $0.00 | 2025-Q1 |
| MORGAN STANLEY | ADD | 1,874,845 | 2,593,615 | +38.3% | $104.4M | 2024-Q4 |
| UBS Group AG | ADD | 328,959 | 618,148 | +87.9% | $24.9M | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 192,280 | 261,635 | +36.1% | $10.5M | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 184,100 | 0 | -100.0% | $0.00 | 2024-Q4 |
| MORGAN STANLEY | ADD | 947,207 | 1,874,845 | +97.9% | $118.7M | 2024-Q3 |
2 unique insiders with 1 transactions. Net insider value: $149.9K ($149.9K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Chen Hubert C | Chief Medical Officer | A | 190,000 | $0.00 | $0.00 |
| Mar 10, 2026 | Aubuchon Neil William | Chief Commercial Officer | BUY | 4,475 | $33.50 | $149.9K |
1 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 2.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (88% buy). Based on 26 analysts: 9 strong buy, 14 buy, 3 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$92.58 mean target
+225.4% upside
Strong Buy (1.45)
$34.00 Low
$125.00 High
| Metric | Value |
|---|---|
| Current Price | $28.45 |
| Target Low | $34.00 |
| Target Mean | $92.58 |
| Target Median | $95.00 |
| Target High | $125.00 |
| # Analysts | 19 |
| Recommendation | Strong Buy (1.45) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-1.21 | $-1.39 | $-0.83 | -108.1% | +1.9% | 3↑ 8↓ | $0.0B | 0.0% | 16 |
| Current FY 2026-12-31 |
$-4.72 | $-5.72 | $-3.81 | -48.1% | +0.1% | 2↑ 11↓ | $0.0B | 0.0% | 16 |
| Next Q 2026-09-30 |
$-1.10 | $-1.45 | $-0.75 | -35.8% | +0.9% | 2↑ 1↓ | $0.0B | 0.0% | 16 |
| Next FY 2027-12-31 |
$-4.57 | $-6.41 | $-2.22 | 3.4% | -0.6% | 2↑ 10↓ | $0.0B | 0.0% | 17 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-1.207 | |
| 7d ago | $-1.230 | +0.023 |
| 30d ago | $-1.230 | +0.023 |
| 60d ago | $-0.982 | -0.225 |
| 90d ago | $-0.982 | -0.225 |
16 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 10 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 28, 2026 | Lake Street | INITIATE | — | Buy |
| May 1, 2026 | BTIG | REITERATE | Buy | Buy |
| Apr 30, 2026 | Cantor Fitzgerald | MAINTAIN | Overweight | Overweight |
| Mar 23, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Nov 12, 2025 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Oct 29, 2025 | Canaccord Genuity | INITIATE | — | Buy |
| Oct 24, 2025 | JP Morgan | MAINTAIN | Overweight | Overweight |
| Oct 23, 2025 | Morgan Stanley | MAINTAIN | Overweight | Overweight |
| Sep 29, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Sep 22, 2025 | BTIG | REITERATE | Buy | Buy |
| Aug 19, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jul 24, 2025 | Raymond James | MAINTAIN | Strong Buy | Strong Buy |
| Jul 24, 2025 | Citigroup | MAINTAIN | Neutral | Neutral |
| Jun 25, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Apr 28, 2025 | Cantor Fitzgerald | INITIATE | — | Overweight |
| Apr 28, 2025 | Truist Securities | REITERATE | Buy | Buy |
| Apr 24, 2025 | Morgan Stanley | MAINTAIN | Overweight | Overweight |
| Apr 24, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Apr 17, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Apr 8, 2025 | Goldman Sachs | INITIATE | — | Neutral |
| Mar 26, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Mar 11, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Feb 13, 2025 | Scotiabank | INITIATE | — | Sector Outperform |
| Feb 7, 2025 | Citigroup | INITIATE | — | Neutral |
| Feb 7, 2025 | Maxim Group | MAINTAIN | Buy | Buy |
| Feb 7, 2025 | B. Riley Securities | REITERATE | Buy | Buy |
| Feb 6, 2025 | Raymond James | MAINTAIN | Strong Buy | Strong Buy |
| Feb 6, 2025 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Feb 6, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jan 17, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jan 10, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jan 8, 2025 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Dec 20, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Dec 18, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Dec 2, 2024 | Piper Sandler | INITIATE | — | Overweight |
| Nov 27, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Nov 26, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Nov 22, 2024 | B. Riley Securities | INITIATE | — | Buy |
| Nov 5, 2024 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Oct 24, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Oct 9, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Sep 25, 2024 | Oppenheimer | REITERATE | Outperform | Outperform |
| Sep 12, 2024 | Morgan Stanley | REITERATE | Overweight | Overweight |
| Sep 11, 2024 | JP Morgan | INITIATE | — | Overweight |
| Jul 25, 2024 | Raymond James | MAINTAIN | Strong Buy | Strong Buy |
| Jul 25, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jun 27, 2024 | Morgan Stanley | INITIATE | — | Overweight |
| Jun 24, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jun 17, 2024 | Truist Securities | MAINTAIN | Buy | Buy |
| Jun 4, 2024 | Raymond James | REITERATE | — | Strong Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 9 | 14 | 3 | 0 | 0 | 88% | |
| May 1, 2026 | 9 | 13 | 3 | 0 | 0 | 88% | |
| Apr 1, 2026 | 9 | 13 | 3 | 0 | 0 | 88% | |
| Mar 1, 2026 | 9 | 13 | 2 | 0 | 0 | 92% | |
| Feb 1, 2026 | 9 | 13 | 2 | 0 | 0 | 92% | |
| Jan 1, 2026 | 9 | 12 | 2 | 0 | 0 | 91% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
50°
Neutral
Bearish
Neutral
Bullish
1 mentions
0 bullish
0 bearish
1 time period
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Feb 12, 2026 | 1 | 44° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
$VKTX - puts
▲ 1
💬 2
⚡ 0.0
May 12, 2026
short_interest
FTD: VKTX — 25,783 shares ($0.8M) failed to deliver
Settlement: 20260512, Price: $31.72, FTD Value: $817,836.76, VIKING THERAPEUTICS INC COM
May 11, 2026
dark_pool
Dark Pool: VKTX — 1.5M shares, 35,388 trades
Week starting 2026-05-11. Total ATS volume: 1,477,445 shares across 35,388 trades.
May 4, 2026
dark_pool
Dark Pool: VKTX — 1.8M shares, 40,591 trades
Week starting 2026-05-04. Total ATS volume: 1,825,999 shares across 40,591 trades.
Apr 29, 2026
earnings_calendar
VKTX Q1 2026 Earnings After Market Close — 2026-04-29
Apr 27, 2026
dark_pool
Dark Pool: VKTX — 3.9M shares, 52,827 trades
Week starting 2026-04-27. Total ATS volume: 3,908,746 shares across 52,827 trades.
Apr 24, 2026
short_volume
Short Volume: VKTX — 55.4% short (0.5M / 0.8M)
Short: 458,092 | Exempt: 100 | TRF Vol: 827,250 | Short Ratio: 55.4% | Off-exchange volume (dark pool + OTC)
Apr 21, 2026
earnings_calendar
VKTX Q1 2026 Earnings After Market Close — 2026-04-21
Apr 20, 2026
dark_pool
Dark Pool: VKTX — 2.1M shares, 37,352 trades
Week starting 2026-04-20. Total ATS volume: 2,137,465 shares across 37,352 trades.
Apr 13, 2026
dark_pool
Dark Pool: VKTX — 1.8M shares, 34,398 trades
Week starting 2026-04-13. Total ATS volume: 1,811,281 shares across 34,398 trades.
Apr 6, 2026
dark_pool
Dark Pool: VKTX — 1.8M shares, 33,627 trades
Week starting 2026-04-06. Total ATS volume: 1,825,268 shares across 33,627 trades.
Mar 30, 2026
dark_pool
Dark Pool: VKTX — 2.1M shares, 39,202 trades
Week starting 2026-03-30. Total ATS volume: 2,082,505 shares across 39,202 trades.
Mar 26, 2026
short_interest
FTD: VKTX — 24,824 shares ($0.8M) failed to deliver
Settlement: 20260326, Price: $33.20, FTD Value: $824,156.8, VIKING THERAPEUTICS INC COM
Mar 23, 2026
dark_pool
Dark Pool: VKTX — 1.9M shares, 37,329 trades
Week starting 2026-03-23. Total ATS volume: 1,924,482 shares across 37,329 trades.
Mar 20, 2026
short_interest
FTD: VKTX — 31,160 shares ($1.1M) failed to deliver
Settlement: 20260320, Price: $33.92, FTD Value: $1,056,947.2, VIKING THERAPEUTICS INC COM
Mar 18, 2026
short_interest
FTD: VKTX — 48,003 shares ($1.7M) failed to deliver
Settlement: 20260318, Price: $35.53, FTD Value: $1,705,546.59, VIKING THERAPEUTICS INC COM